Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

  //science-technology.news-articles.ne .. now-available-for-online-viewing.html
  Published in Science and Technology on Thu, Sep 9th, 2025 by Toronto Star

Life Sciences Virtual Investor Forum: Recordings Now Online for Global Viewers

A major milestone has been reached for investors and stakeholders interested in Canada’s rapidly expanding life‑sciences sector. Following the highly‑anticipated virtual investor forum that took place on June 5, 2024, all of the event’s presentations have been made available for on‑demand viewing. The recordings can now be accessed through a dedicated web portal linked in the GlobeNewswire press release distributed to The Star, and they provide a comprehensive look at the latest breakthroughs, pipeline strategies, and investment opportunities within the life‑sciences ecosystem.

What Was the Virtual Investor Forum?

The forum was organized by the Life Sciences Investor Forum (LSIF), a non‑profit association that brings together public‑sector investors, private‑sector partners, entrepreneurs, and thought leaders from across Canada’s life‑sciences industry. Its purpose is to showcase Canadian companies at various stages—from pre‑clinical research to commercialization—while facilitating meaningful dialogue between capital providers and innovators.

In 2024, the LSIF adapted the format from a fully in‑person event to a hybrid virtual platform. The virtual forum was structured as follows:

1. Opening Keynote – Delivered by Dr. Laura St. John, Vice‑Chair of the Canadian Life Sciences Association, highlighting the sector’s growth trajectory and the role of foreign direct investment in accelerating Canadian innovation.
2. Company Presentations – Eight Canadian companies presented their current pipeline, business model, and funding needs. These included biotech, diagnostics, and digital‑health firms that had raised recent capital or were approaching pivotal clinical milestones.
3. Investor Q&A Sessions – Each presentation was followed by a moderated question and answer segment, allowing investors to probe technical details, commercialization strategies, and regulatory pathways.
4. Closing Panel – A discussion on emerging trends such as precision medicine, gene therapy, and AI‑driven drug discovery, moderated by industry analysts.

The virtual format eliminated geographic constraints and allowed participants from North America, Europe, and Asia to attend simultaneously. Attendance numbers exceeded 1,200, making it the largest life‑sciences investor event in Canadian history.

Highlights of the Recordings

The on‑demand portal provides full‑length, high‑definition video of each presentation, complete with downloadable slide decks and supplementary materials. Key highlights include:

• Biotech Company Spotlight: GenEvo Therapeutics showcased its first‑in‑class RNA‑based therapeutic for rare neurological disorders, demonstrating data from a Phase I trial that met all safety endpoints.
• Diagnostic Innovation: ClearPath Diagnostics unveiled a rapid point‑of‑care test for early detection of sepsis, featuring a partnership with the Ontario Ministry of Health to pilot the test in 12 hospitals.
• Digital‑Health Breakthrough: MindSync Health presented its AI‑driven cognitive training platform for patients with mild cognitive impairment, highlighting integration with electronic health records to personalize interventions.
• Gene‑Editing Pioneer: CRISPRx Canada detailed its CRISPR‑Cas12a platform for ex‑ vivo editing of T cells, with a focus on improving manufacturing scalability and reducing off‑target effects.

Each presentation is segmented by company name and topic, making it easy for investors to navigate to their areas of interest. The video transcripts are also available, supporting accessibility and enabling further research.

Investor Takeaways

The recordings are designed to give investors the same level of insight they would have gained from attending the live event. The detailed Q&A sessions address common investor concerns such as:

• Pipeline Development: Time‑to‑market estimates, regulatory hurdles, and milestone funding structures.
• Financial Projections: Revenue forecasts, cost‑structure assumptions, and sensitivity analyses.
• Strategic Partnerships: Collaborations with academic institutions, contract manufacturing organizations, and global pharmaceutical partners.

By making the content freely available, LSIF reinforces its commitment to transparency and knowledge sharing, ensuring that capital flows more efficiently into high‑impact life‑sciences initiatives.

How to Access the Recordings

The recordings can be accessed by visiting the dedicated portal linked in the GlobeNewswire release. The URL directs users to a secure, password‑protected page that requires a short registration (name, email, and affiliation). Once registered, participants receive a link to a playlist of all eight company presentations, organized by category. The portal also hosts:

• PDF versions of the slide decks
• Contact information for each company’s investor relations team
• FAQs and guidance on how to engage further (e.g., request for a one‑on‑one meeting, participation in future roadshows)

The portal remains open for 30 days from the release date, after which recordings may be archived. However, LSIF has announced that they will keep a “classic” archive available for reference on their main website.

Next Steps and Future Events

The LSIF announced that the next virtual investor forum will be held in September 2024, focusing on “Digital Health and AI in Biopharma.” The organization also plans to host a series of webinars on venture financing and regulatory pathways in Canada.

For those who missed the live event, the on‑demand recordings offer a rich, interactive experience. Investors can now revisit company presentations, re‑watch the Q&A sessions, and download supplementary data—all without leaving their desks.

In summary, the Life Sciences Virtual Investor Forum’s new online archive is a valuable resource for any stakeholder looking to stay abreast of Canada’s most promising biotech and health‑tech companies. Whether you’re a seasoned venture capitalist, a corporate investor, or an academic researcher, the detailed presentations and supporting materials provide an unprecedented window into the next generation of life‑sciences innovations.